Teva Pharmaceutical Industries Ltd. — Proxy Solicitation & Information Statement 2008

Sep 16, 2008

_________ false

C003��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.2530Corporation no: 520013954Stock Exchange/Market: ���310381P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267554 , 03-9267652 Fax: 03-9267519E.mail address: elana.holzman@teva.co.ilDate of transmission: 16/09/2008              Time of broadcast: 14:39 10:51:23

Reference: 2008-02-267105

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	preliminary F-4 Registration and Proxy Statement, which was filed today with the US Securities and Exchange Commission in connection with the Barr acquisition.

legal150908_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 21/07/2008
- - -
Name of the Signatory: : Karniel Uzi , Position of Signatory in the reporting corporation: General Counsel & Company Secretary , Name of Employer Company: .
Basel Telephone: 03-9267297 , Facsimile: 03-9267429 , E-mail: uzi.karniel@teva.co.il 1